Literature DB >> 3302727

Induction of protective immunity against experimental infection with malaria using synthetic peptides.

M E Patarroyo, P Romero, M L Torres, P Clavijo, A Moreno, A Martínez, R Rodríguez, F Guzman, E Cabezas.   

Abstract

Synthetic peptides are potential vaccine candidates because they may be able to induce high antibody titres and specific cellular immune responses against native proteins and thus the whole invading organism. In a previous study we showed that immunization with molecules of relative molecular mass (Mr) 155,000 (155K) 83K, 55K and 35K, specific for the late schizont and merozoite stages of Plasmodium falciparum, could elicit either partial or total protection in Aotus trivirgatus monkeys experimentally infected with P. falciparum. Here we have chemically synthesized 18 peptides corresponding to different fragments of these proteins to immunize Aotus trivirgatus monkeys. Some peptides gave partial protection from challenge with P. falciparum parasites, but none provided complete protection individually. A combination of three partially protective peptides gave complete or almost complete protection, however, suggesting that this particular combination of peptides is a good candidate for a malaria vaccine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3302727     DOI: 10.1038/328629a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  51 in total

1.  Inhibition of bacterial superantigens by peptides and antibodies.

Authors:  K Visvanathan; A Charles; J Bannan; P Pugach; K Kashfi; J B Zabriskie
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 3.  Vaccines for tomorrow.

Authors:  S K Sood
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

4.  In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.

Authors:  Alan L Y Pang; Caryn N Hashimoto; Leslie Q Tam; Z Q Meng; George S N Hui; Walter K K Ho
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

5.  Conservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility complex class II haplotypes.

Authors:  Junzo Norimine; Juan Mosqueda; Guy H Palmer; Harris A Lewin; Wendy C Brown
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

6.  Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.

Authors:  G S Hui; A Hashimoto; S P Chang
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria.

Authors:  M Salcedo; L Barreto; M Rojas; R Moya; J Cote; M E Patarroyo
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

8.  MHC class I genes in the owl monkey: mosaic organisation, convergence and loci diversity.

Authors:  Paula P Cardenas; Carlos F Suarez; Pilar Martinez; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Immunogenetics       Date:  2005-01-15       Impact factor: 2.846

9.  Reference strand conformational analysis (RSCA) is a valuable tool in identifying MHC-DRB sequences in three species of Aotus monkeys.

Authors:  Juan E Baquero; Santiago Miranda; Oscar Murillo; Heidy Mateus; Esperanza Trujillo; Carlos Suarez; Manuel E Patarroyo; Carlos Parra-López
Journal:  Immunogenetics       Date:  2006-05-30       Impact factor: 2.846

Review 10.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.